124 related articles for article (PubMed ID: 37961183)
1. A Germline Point Mutation in the MYC-FBW7 Phosphodegron Initiates Hematopoietic Malignancies.
Freie B; Carroll PA; Varnum-Finney BJ; Ramani V; Bernstein I; Eisenman RN
bioRxiv; 2023 Oct; ():. PubMed ID: 37961183
[TBL] [Abstract][Full Text] [Related]
2. Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor.
Welcker M; Wang B; Rusnac DV; Hussaini Y; Swanger J; Zheng N; Clurman BE
Sci Adv; 2022 Jan; 8(4):eabl7872. PubMed ID: 35089787
[TBL] [Abstract][Full Text] [Related]
3. T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.
Daniel CJ; Pelz C; Wang X; Munks MW; Ko A; Murugan D; Byers SA; Juarez E; Taylor KL; Fan G; Coussens LM; Link JM; Sears RC
Mol Cancer Res; 2022 Jul; 20(7):1151-1165. PubMed ID: 35380701
[TBL] [Abstract][Full Text] [Related]
4. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
5. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
[TBL] [Abstract][Full Text] [Related]
6. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7.
Thompson BJ; Jankovic V; Gao J; Buonamici S; Vest A; Lee JM; Zavadil J; Nimer SD; Aifantis I
J Exp Med; 2008 Jun; 205(6):1395-408. PubMed ID: 18474632
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland.
Wang X; Cunningham M; Zhang X; Tokarz S; Laraway B; Troxell M; Sears RC
Cancer Res; 2011 Feb; 71(3):925-36. PubMed ID: 21266350
[TBL] [Abstract][Full Text] [Related]
8. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism.
Cartwright P; McLean C; Sheppard A; Rivett D; Jones K; Dalton S
Development; 2005 Mar; 132(5):885-96. PubMed ID: 15673569
[TBL] [Abstract][Full Text] [Related]
9. Altering MYC phosphorylation in the epidermis increases the stem cell population and contributes to the development, progression, and metastasis of squamous cell carcinoma.
Wang X; Langer EM; Daniel CJ; Janghorban M; Wu V; Wang XJ; Sears RC
Oncogenesis; 2020 Sep; 9(9):79. PubMed ID: 32895364
[TBL] [Abstract][Full Text] [Related]
10. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH
Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469
[TBL] [Abstract][Full Text] [Related]
11. A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin-low human breast cancer.
Hollern DP; Yuwanita I; Andrechek ER
Oncogene; 2013 Mar; 32(10):1296-304. PubMed ID: 22525269
[TBL] [Abstract][Full Text] [Related]
12. Differential Transcriptional Reprogramming by Wild Type and Lymphoma-Associated Mutant MYC Proteins as B-Cells Convert to a Lymphoma Phenotype.
Mahani A; Arvidsson G; Sadeghi L; Grandien A; Wright APH
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885204
[TBL] [Abstract][Full Text] [Related]
13. Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant.
Thibodeaux CA; Liu X; Disbrow GL; Zhang Y; Rone JD; Haddad BR; Schlegel R
Breast Cancer Res Treat; 2009 Jul; 116(2):281-94. PubMed ID: 18642118
[TBL] [Abstract][Full Text] [Related]
14. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.
Chang DW; Claassen GF; Hann SR; Cole MD
Mol Cell Biol; 2000 Jun; 20(12):4309-19. PubMed ID: 10825194
[TBL] [Abstract][Full Text] [Related]
15. Immortalization of human neural stem cells with the c-myc mutant T58A.
De Filippis L; Ferrari D; Rota Nodari L; Amati B; Snyder E; Vescovi AL
PLoS One; 2008 Oct; 3(10):e3310. PubMed ID: 18836552
[TBL] [Abstract][Full Text] [Related]
16. Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations.
Thirimanne HN; Wu F; Janssens DH; Swanger J; Diab A; Feldman HM; Amezquita RA; Gottardo R; Paddison PJ; Henikoff S; Clurman BE
Elife; 2022 Feb; 11():. PubMed ID: 35225231
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations in Myc Box I influence nucleocytoplasmic transport to promote leukemogenesis.
Arthur NB; Christensen KA; Mannino K; Ruzinova MB; Kumar A; Gruszczynska A; Day RB; Erdmann-Gilmore P; Mi Y; Sprung R; York CR; Townsend RR; Spencer DH; Sykes SM; Ferraro F
Clin Cancer Res; 2024 Jun; ():. PubMed ID: 38848040
[TBL] [Abstract][Full Text] [Related]
18. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.
Welcker M; Orian A; Grim JE; Eisenman RN; Clurman BE
Curr Biol; 2004 Oct; 14(20):1852-7. PubMed ID: 15498494
[TBL] [Abstract][Full Text] [Related]
19. MYC activity is negatively regulated by a C-terminal lysine cluster.
Wasylishen AR; Kalkat M; Kim SS; Pandyra A; Chan PK; Oliveri S; Sedivy E; Konforte D; Bros C; Raught B; Penn LZ
Oncogene; 2014 Feb; 33(8):1066-72. PubMed ID: 23435422
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.
Yada M; Hatakeyama S; Kamura T; Nishiyama M; Tsunematsu R; Imaki H; Ishida N; Okumura F; Nakayama K; Nakayama KI
EMBO J; 2004 May; 23(10):2116-25. PubMed ID: 15103331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
